T1	condition 80 102	upper limb dysfunction
T2	intervention 30 76	sodium hyaluronate and carboxymethyl cellulose
T3	No-of-participants 759 761	99
T4	intervention-participants 857 859	50
T5	control 974 987	control group
T6	control-participants 993 995	49
T7	control 1015 1040	without the use of HA-CMC
T8	outcome-Measure 1068 1087	ROM of the shoulder
T9	outcome-Measure 1092 1111	motion-related pain
T10	outcome-Measure 1251 1301	disabilities of the arm, shoulder, and hand (DASH)
T11	outcome-Measure 1310 1338	pectoralis minor length test
T12	outcome 1405 1466	reductions in postoperative restriction of total shoulder ROM
T13	outcome 1547 1602	pain levels related to flexion and horizontal abduction
T14	outcome 1695 1705	DASH score
